Psychedelic Medicine Medical Interest Group
Resources
-
The Psychedelic Association of Canada has compiled a list of training programs (including offerings from Roots to Thrive, ATMA CENA, and TheraPsil among others) which can be viewed on their website.
If you are involved in running a training program or opportunity and it is not already included on the list, please feel free to contact us with the details so that we can share them here.
The Ketamine Learning Experience (KLE) is a 5 day / 4 night residential experience — both didactic and experiential — that has been offered by Dr. Mark Cornfield (retired psychiatrist/therapist) and his partner Susan McBride (retired nurse/therapist) since 2019. This workshop takes place in Brantford ON and is a powerful group experience (with no more than 10 participants in any one group) that has received excellent evaluations from over 100 physicians and over 150 therapists who have attended. The workshop covers all one needs to know about ketamine, with a heavy emphasis on working with people in all phases of non-ordinary consciousness, and includes an experience of holotropic breathwork as well as other experiential inputs. For further information, please contact Dr. Mark Cornfield at mjcornfield@gmail.com.
-
The Ketamine Assisted Therapy Association of Canada (KATA) collaborated with the OMA MIG on Psychedelic Medicine to develop the latest version of the Outpatient Use of Ketamine for Mental Health Conditions Practice Standards Recommendations as a guide to regulators as well as to professionals prescribing and delivering non-intravenous routes of ketamine in community settings. These recommendations were written collaboratively by an interdisciplinary team after a literature review of 53 key articles, hospital protocols, existing practice guidelines and additional data from outpatient practices and was reviewed by a panel of peers. The practice recommendations will continue to evolve as new research and clinical data emerges and as feedback is received from the ketamine practice community.
The document can be accessed through KATA’s website: https://katacanada.org/resources/practice-standards/
-
The Psychedelic Association of Canada has compiled a list of research findings which can be filtered by substance and condition.
The Psychedelic Alpha website contains a tracker mapping out psychedelic drug discovery and development activity.
The UC Berkeley Center for the Science of Psychedelics website contains a clinical trials map (featuring data from ClinicalTrials.gov) to navigate past, ongoing, and future trials.
The Ketamine Research Institute has a list of recommended readings about psychotherapeutic ketamine on their website.
-
Psychedelic Science: https://www.psychedelicscience.org/
Interdisciplinary Conference on Psychedelic Research (ICPR): https://www.icpr-conference.com/
American Society of Ketamine Physicians, Psychotherapists, & Practitioners (ASKP3): https://askp.org/annual-conference-attendees/
-
MAPS Canada has a Clinical Research Community of Practice which aims to cultivate a collaborative environment where clinicians, researchers, policy experts, and advocates can exchange best practices, discuss challenges, and align on quality, ethics, and protocols in psychedelic clinical research.
MAPS Canada also has a Psychedelic Access Community of Practice which aims to bring together professionals interested in advancing access to psychedelics in compliance with the law.
Google Groups:
Big Tent Ketamine: Apply to join here.
Ketamine and Colleges: A group of Canadian physicians organized to try to coordinate efforts across Canada to negotiate with the provincial colleges around the regulation of ketamine and other psychedelic medicines. Please contact Dr. Mark Cornfield at mjcornfield@gmail.com to join.
-
Psychedelic Lived Experiences: https://psychedeliclivedexperiences.com/